Literature DB >> 17982310

Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists.

Rolf P Kreutz1, Udaya S Tantry, Kevin P Bliden, Paul A Gurbel.   

Abstract

Epidemiologic studies have shown increased rates of myocardial infarction after upper respiratory tract infections. We hypothesized that changes in platelet activation and reactivity and inflammation occur during the 'common cold'. Previously healthy individuals with viral upper respiratory tract infections were studied (n = 18). Venous blood samples were obtained during the time of infection and again after 6 weeks. Platelet reactivity was higher during the 'common cold' as measured by low-dose ADP-induced aggregation (46 +/- 28 versus 27 +/- 21% 6 weeks after presentation, P = 0.003) and was higher than control individuals (22 +/- 8%, P = 0.003). Platelet P-selectin expression increased during illness (2.3 +/- 0.2% CD62-positive platelets versus 1.8 +/- 0.1% at 6 weeks after presentation, P = 0.017; and 1.7 +/- 0.2% in the control group, P = 0.03). C-reactive protein (3.7 +/- 1.3 versus 2.2 +/- 1.5 mg/l, P = 0.004) and tumor necrosis factor-alpha (27.6 +/- 28 versus 12.7 +/- 9 pg/ml, P = 0.03) were increased during the 'common cold'. There were no significant differences in levels of soluble P-selectin (P = 0.18), soluble vascular adhesion molecule-1 (P = 0.59) and soluble intercellular adhesion molecule-1 (P = 0.23). Increased platelet reactivity and activation during the 'common cold' are associated with inflammation as measured by increased levels of C-reactive protein and tumor necrosis factor-alpha, but not increased levels of endothelial markers. These findings support a pro-aggregatory state that, in part, explains the thrombotic events shown by epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982310     DOI: 10.1097/MBC.0b013e328201c77e

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  15 in total

1.  Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin.

Authors:  Rolf P Kreutz; Perry Nystrom; Yvonne Kreutz; Jia Miao; Richard Kovacs; Zeruesenay Desta; David A Flockhart; Yan Jin
Journal:  Platelets       Date:  2012-03-02       Impact factor: 3.862

2.  Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.

Authors:  Rolf P Kreutz; Jeffrey A Breall; Yvonne Kreutz; Janelle Owens; Deshun Lu; Islam Bolad; Elisabeth von der Lohe; Anjan Sinha; David A Flockhart
Journal:  Thromb Res       Date:  2012-03-28       Impact factor: 3.944

3.  Underestimated Ischemic Heart Disease in Major Adverse Cardiovascular Events after Septicemia Discharge.

Authors:  Chih-Chun Hsiao; Yao-Ming Huang; Yin-Han Chang; Hui-Chen Lin; Wu-Chien Chien; Chun-Gu Cheng; Chun-An Cheng
Journal:  Medicina (Kaunas)       Date:  2022-05-31       Impact factor: 2.948

4.  C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.

Authors:  Rolf P Kreutz; Janelle Owens; Jeffrey A Breall; Deshun Lu; Elisabeth von der Lohe; Islam Bolad; Anjan Sinha; David A Flockhart
Journal:  Blood Coagul Fibrinolysis       Date:  2013-04       Impact factor: 1.276

5.  Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.

Authors:  Rolf P Kreutz; Abbas Bitar; Janelle Owens; Zeruesenay Desta; Jeffrey A Breall; Elisabeth von der Lohe; Anjan Sinha; Matteo Vatta; Perry Nystrom; Yan Jin; David A Flockhart
Journal:  J Thromb Thrombolysis       Date:  2014-10       Impact factor: 2.300

6.  Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.

Authors:  Rolf P Kreutz; Janelle Owens; Deshun Lu; Perry Nystrom; Yan Jin; Yvonne Kreutz; Zeruesenay Desta; David A Flockhart
Journal:  Platelets       Date:  2014-05-15       Impact factor: 3.862

7.  Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity.

Authors:  Rolf P Kreutz; Mouhamad Alloosh; Khaled Mansour; Zachary Neeb; Yvonne Kreutz; David A Flockhart; Michael Sturek
Journal:  Diabetes Metab Syndr Obes       Date:  2011-03-15       Impact factor: 3.168

8.  Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response.

Authors:  Rolf P Kreutz; Perry Nystrom; Yvonne Kreutz; Jia Miao; Zeruesenay Desta; Jeffrey A Breall; Lang Li; Chienwei Chiang; Richard Kovacs; David A Flockhart; Yan Jin
Journal:  Clin Pharmacol       Date:  2012-02-20

9.  Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin.

Authors:  Marco Falcone; Alessandro Russo; Roberto Cangemi; Alessio Farcomeni; Camilla Calvieri; Francesco Barillà; Maria Gabriella Scarpellini; Giuliano Bertazzoni; Paolo Palange; Gloria Taliani; Mario Venditti; Francesco Violi
Journal:  J Am Heart Assoc       Date:  2015-01-06       Impact factor: 5.501

10.  Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response.

Authors:  Rolf P Kreutz; Janelle Owens; Yan Jin; Perry Nystrom; Zeruesenay Desta; Yvonne Kreutz; Jeffrey A Breall; Lang Li; Chienwei Chiang; Richard J Kovacs; David A Flockhart
Journal:  Clin Pharmacol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.